万东医疗
(600055)
| 流通市值：72.91亿 | | | 总市值：72.91亿 |
| 流通股本：7.03亿 | | | 总股本：7.03亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 874,647,955.08 | 406,568,573.28 | 1,346,993,071.19 | 1,188,509,072.63 |
| 营业收入 | 874,647,955.08 | 406,568,573.28 | 1,346,993,071.19 | 1,188,509,072.63 |
| 二、营业总成本 | 967,898,771.64 | 432,413,033.27 | 1,633,905,567.43 | 1,236,567,549.4 |
| 营业成本 | 656,474,422.08 | 305,655,543.93 | 989,174,287.69 | 800,794,501.54 |
| 税金及附加 | 5,102,322.99 | 868,193.13 | 13,286,258.47 | 7,842,866.5 |
| 销售费用 | 133,817,733.94 | 55,776,717.4 | 277,078,445.99 | 197,899,218.04 |
| 管理费用 | 47,389,420.31 | 18,653,909.35 | 129,251,384.08 | 79,816,094.79 |
| 研发费用 | 119,771,905.96 | 52,385,903.72 | 263,190,676.1 | 182,109,966.93 |
| 财务费用 | 5,342,966.36 | -927,234.26 | -38,075,484.9 | -31,895,098.4 |
| 其中:利息费用 | 284,531.26 | - | 1,272,653.49 | 558,734.77 |
| 其中:利息收入 | 18,130,355.69 | 9,003,775.37 | 52,545,470.84 | 37,861,327.81 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 387,671.22 | 772,438.36 | -865,057.31 | 375,753.42 |
| 加:投资收益 | 9,922,354.71 | 519,561.61 | 5,111,530.18 | 3,790,558.47 |
| 资产处置收益 | -28,704.41 | -6,430.77 | -83,676.9 | -70,123.79 |
| 资产减值损失(新) | 75 | - | -20,304,431.61 | - |
| 信用减值损失(新) | -24,168,125.25 | 1,133,478.21 | -46,112,441.01 | -13,053,214.07 |
| 其他收益 | 13,772,887.1 | 8,733,380.91 | 51,981,348.54 | 35,817,348.55 |
| 四、营业利润 | -93,364,658.19 | -14,692,031.67 | -297,185,224.35 | -21,198,154.19 |
| 加:营业外收入 | 3,247.86 | 3,247.86 | 379,100 | - |
| 减:营业外支出 | 982,970.53 | 934,970.53 | 3,708,484 | - |
| 五、利润总额 | -94,344,380.86 | -15,623,754.34 | -300,514,608.35 | -21,198,154.19 |
| 减:所得税费用 | -3,842,887.39 | 372.15 | -72,721,170.29 | 6,348,317.64 |
| 六、净利润 | -90,501,493.47 | -15,624,126.49 | -227,793,438.06 | -27,546,471.83 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -90,501,493.47 | -15,624,126.49 | -227,793,438.06 | -27,546,471.83 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -91,667,605.8 | -15,934,047.3 | -227,860,105.15 | -27,209,818.77 |
| 少数股东损益 | 1,166,112.33 | 309,920.81 | 66,667.09 | -336,653.06 |
| 扣除非经常损益后的净利润 | -102,174,266.15 | -18,033,851.63 | -245,185,499.48 | -44,575,434.71 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.13 | -0.02 | -0.32 | -0.04 |
| (二)稀释每股收益 | -0.13 | -0.02 | -0.32 | -0.04 |
| 八、其他综合收益 | - | - | 2,821,150 | - |
| 归属于母公司股东的其他综合收益 | - | - | 2,821,150 | - |
| 九、综合收益总额 | -90,501,493.47 | -15,624,126.49 | -224,972,288.06 | -27,546,471.83 |
| 归属于母公司股东的综合收益总额 | -91,667,605.8 | -15,934,047.3 | -225,038,955.15 | -27,209,818.77 |
| 归属于少数股东的综合收益总额 | 1,166,112.33 | 309,920.81 | 66,667.09 | -336,653.06 |
| 公告日期 | 2026-08-26 | 2026-04-25 | 2026-03-26 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |